Tolerability of monoclonal antibodies in multiple myeloma
How can MRD and disease be assessed in routine practice?
Recent investigational advances in the management of relapsed/refractory myeloma
Recent drug approvals for the treatment of relapsed/refractory multiple myeloma
Treatment landscape for high-risk multiple myeloma patients